SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Hypertriglyceridemia as Key Factor to Abdominal Aortic Aneurysm Development and Rupture: Genetic and Experimental Evidence

Dr. Juan Manuel Pérez - 10 November, 2025 0

Abdominal aortic aneurysm (AAA) is a deadly vascular disease with no effective drug treatment, and risk of rupture reaching up to 80%. Even though...

CALIPSO: Calcified Lesions and Use of OCT

Dr. Omar Tupayachi - 10 November, 2025 0

Percutaneous coronary intervention (PCI) in calcified lesions remains one of the most challenging scenarios in daily practice, as these lesions are often accompanied by...

Atrial Fibrillation and Chronic Kidney Disease: Outcomes of Different Stroke Prevention Strategies

Dr. Andrés Rodríguez - 5 November, 2025 0

Atrial fibrillation (AF) affects approximately 1 in every 4 patients with end-stage renal disease (ESRD). This population carries a high burden of comorbidities and...

Noticias Institucionales

SOL SOLACI performed a new procedure in Argentina using bioabsorbable stents in pulmonary branches

solaci - 29 October, 2025 0

The SOLACI Solidarity Program carried out a new procedure on a patient from the region of Frías, in Santiago del Estero (Argentina), during October...

Venezuela 2025 Sessions | Young Interventional Cardiologists Contest

solaci - 17 October, 2025 0

Call for Case Submissions LIII SOLACI Regional Sessions – 18th Andean Region We invite all young Latin American cardiologists to submit clinically relevant interventional cardiology cases...

See the Best Moments from the Costa Rica 2025 Sessions

solaci - 17 October, 2025 0

Relive the most remarkable highlights of the Costa Rica 2025 Sessions, held from October 8 to 10, 2025, at the Intercontinental Hotel in San...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: primary prevention

LpA: 30-Year Cardiovascular Followup in Primary Prevention Cohorts

Latest News on AHA/ACC Primary Prevention Guidelines

AHA 2020 | POLYPILL: One Pill Plus Aspirin to Treat Everything

The FDA Approves Ticagrelor for Primary Prevention in High Risk Patients

The Elderly and Polypharmacy: What to Discontinue

Statins in Primary Prevention: As Questioned as Aspirin?

Primary Prevention Guidelines Published for the First Time: Are They Useful...

Aspirin in Primary Prevention: Another “Trendy” Topic in Publications

ACC 2019 | The New ACC/AHA Guidelines on Primary Prevention Focus...

ESC 2018 | ARRIVE: Aspirin in the Eye of the Storm...